On 23 July 2022, Tim Nguyen, Unit Head of Global Infectious Hazards Preparedness at WHO's Emergency Program, stated at a press conference that everyone who had received the Monkeypox vaccine was considered part of a "clinical trial" to collect data so that researchers could learn more about the vaccine's "effectiveness". The efficacy of the vaccine was and still is unknown because it has never been used on this scale before.
top of page
bottom of page